Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 24

Results For "therapeutic"

1823 News Found

Raay Neo Pharma launches operations to expand access to quality healthcare across India
News | April 27, 2026

Raay Neo Pharma launches operations to expand access to quality healthcare across India

Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies


Vision 360 brings academia, industry together to advance ophthalmic therapies
Healthcare | April 25, 2026

Vision 360 brings academia, industry together to advance ophthalmic therapies

VESCOP, ENTOD Pharmaceuticals, and APTI-MSB host the event to bridge lab-to-clinic gap in eye care


ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma
Clinical Trials | April 24, 2026

ModeX doses first patients in trial of next-gen T-cell engager for aggressive B-cell lymphoma

The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack


Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes
R&D | April 23, 2026

Sanplatec selects Mitsubishi Chemical’s Zelas TPS for new cell culture tubes

Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport


Cipla’s generic Ventolin HFA secures USFDA approval
Drug Approval | April 23, 2026

Cipla’s generic Ventolin HFA secures USFDA approval

Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market


Experts convene in India to push for urgent action on dengue treatment gaps
Public Health | April 23, 2026

Experts convene in India to push for urgent action on dengue treatment gaps

Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches


Asahi Kasei pushes into human trials with new autoimmune drug candidate
Clinical Trials | April 22, 2026

Asahi Kasei pushes into human trials with new autoimmune drug candidate

The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp


New guardian protein mechanism identified in aggressive skin cancer progression
R&D | April 22, 2026

New guardian protein mechanism identified in aggressive skin cancer progression

While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies


US FDA okays Merck's new once-daily HIV pill
Drug Approval | April 22, 2026

US FDA okays Merck's new once-daily HIV pill

The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir


Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
Clinical Trials | April 22, 2026

Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease

By cutting pain crises & boosting haemoglobin